Vertaling van "profile of medicines " (Nederlands → Frans) :

Thanks to the introduction of a proactive vigilance policy within the FAMHP via the PROACTIVE VIGILANCE spearhead, the safety profile of medicines and health products will be better known, thereby also promoting safer use of these products.
Thanks to the introduction of a proactive vigilance policy within the FAMHP via the PROACTIVE VIGILANCE spearhead, the safety profile of medicines and health products will be better known, thereby also promoting safer use of these products.

By definition, these are the medicines for which it is very important to gather data so as to be able to determine their safety profile more accurately.
By definition, these are the medicines for which it is very important to gather data so as to be able to determine their safety profile more accurately.

Certican (USD 34 million, +36% cc), a transplantation medicine, is now available in more than 70 countries for use in the prevention of organ rejection based on its immunosuppressive efficacy and side-effect profile.
Aclasta/Reclast (USD 123 millions, +41% tcc) a conservé un rythme élevé de croissance soutenu par les Etats-Unis et par une extension du nombre de pays où il est commercialisé.

This medicine, which has the same active ingredient as Afinitor (everolimus), has been shown to have good immunosuppressive efficacy and a manageable side-effect profile.
Ce médicament qui contient de l’évérolimus, la même substance active qu’Afinitor, a démontré une bonne efficacité immunosuppressive et un profil d’effets secondaires gérables.

Exforge (USD 304 million +96% lc), a single pill containing the angiotensin receptor blocker Diovan (valsartan) and the calcium channel blocker amlodipine, has been steadily outpacing the high blood pressure medicine market due to its differentiated efficacy profile.
Exforge (USD 304 millions, +96% en m. l.), un comprimé associant Diovan (valsartan), un inhibiteur des récepteurs de l’angiotensine et l’amlodipine, un inhibiteur des canaux calciques, a constamment surpassé le marché des médicaments contre la pression sanguine élevée grâce à son profil différencié d’efficacité.